DK3484880T3 - Heteroaromatiske modulatorer af retinoid-relateret orphan receptor gamma - Google Patents

Heteroaromatiske modulatorer af retinoid-relateret orphan receptor gamma Download PDF

Info

Publication number
DK3484880T3
DK3484880T3 DK17737284.4T DK17737284T DK3484880T3 DK 3484880 T3 DK3484880 T3 DK 3484880T3 DK 17737284 T DK17737284 T DK 17737284T DK 3484880 T3 DK3484880 T3 DK 3484880T3
Authority
DK
Denmark
Prior art keywords
orphane
retinoid
heteroaromatic
modulators
receptor gamma
Prior art date
Application number
DK17737284.4T
Other languages
Danish (da)
English (en)
Inventor
Alan Stuart Jessiman
Patrick Stephen Johnson
Kristoffer Maansson
Morten Dahl Sørensen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of DK3484880T3 publication Critical patent/DK3484880T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DK17737284.4T 2016-07-13 2017-07-11 Heteroaromatiske modulatorer af retinoid-relateret orphan receptor gamma DK3484880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16020268 2016-07-13
PCT/EP2017/067390 WO2018011201A1 (en) 2016-07-13 2017-07-11 Heteroaromatic modulators of the retinoid-related orphan receptor gamma

Publications (1)

Publication Number Publication Date
DK3484880T3 true DK3484880T3 (da) 2020-11-09

Family

ID=56511303

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17737284.4T DK3484880T3 (da) 2016-07-13 2017-07-11 Heteroaromatiske modulatorer af retinoid-relateret orphan receptor gamma

Country Status (21)

Country Link
US (2) US10662181B2 (cg-RX-API-DMAC7.html)
EP (1) EP3484880B1 (cg-RX-API-DMAC7.html)
JP (1) JP7016344B2 (cg-RX-API-DMAC7.html)
KR (1) KR102490140B1 (cg-RX-API-DMAC7.html)
CN (1) CN109476653B (cg-RX-API-DMAC7.html)
AU (1) AU2017294969B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019000486A2 (cg-RX-API-DMAC7.html)
CA (1) CA3030370A1 (cg-RX-API-DMAC7.html)
DK (1) DK3484880T3 (cg-RX-API-DMAC7.html)
ES (1) ES2834009T3 (cg-RX-API-DMAC7.html)
IL (1) IL264141B (cg-RX-API-DMAC7.html)
MX (1) MX383770B (cg-RX-API-DMAC7.html)
MY (1) MY196990A (cg-RX-API-DMAC7.html)
PL (1) PL3484880T3 (cg-RX-API-DMAC7.html)
PT (1) PT3484880T (cg-RX-API-DMAC7.html)
RU (1) RU2771280C2 (cg-RX-API-DMAC7.html)
SA (1) SA519400868B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201811107WA (cg-RX-API-DMAC7.html)
UA (1) UA123330C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018011201A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201808436B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2771280C2 (ru) * 2016-07-13 2022-04-29 Лео Фарма А/С Гетероароматические модуляторы ретинол-связанного орфанного рецептора гамма
CN111825654A (zh) * 2019-04-19 2020-10-27 北京酷瓴生物技术有限公司 苯甲烯哌啶衍生物及其制备方法、中间体和用途
CN112898292A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS244821B2 (en) * 1983-06-16 1986-08-14 Boehringer Ingelheim Ltd Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
WO2004073612A2 (en) 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
FR2879381B1 (fr) 2004-12-15 2008-12-26 Thales Sa Systeme de distribution quantique de cle de cryptage a variables continues
MX2007012392A (es) * 2005-04-04 2007-12-05 Ab Science Derivados de oxazol sustituidos y su uso como inhibidores de tirosina cinasa.
EP2511275A1 (en) 2011-04-12 2012-10-17 Bioprojet Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
SI2928885T1 (sl) * 2012-12-06 2017-06-30 Glaxo Group Limited Modulatorji retinoidnemu sorodnega receptorja gama sirote (ror-gama) za uporabo pri zdravljenju avtoimunskih in vnetnih bolezni
WO2015067575A1 (en) * 2013-11-05 2015-05-14 F. Hoffmann-La Roche Ag 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases
WO2015180613A1 (en) * 2014-05-28 2015-12-03 Glaxosmithkline Intellectual Property Development Limited Novel compounds
WO2015180612A1 (en) 2014-05-28 2015-12-03 Glaxosmithkline Intellectual Property Development Limited Novel compounds
ES2716966T3 (es) * 2014-05-28 2019-06-18 Glaxosmithkline Ip Dev Ltd Derivados de piperazina como moduladores de ROR-gamma
RU2771280C2 (ru) * 2016-07-13 2022-04-29 Лео Фарма А/С Гетероароматические модуляторы ретинол-связанного орфанного рецептора гамма

Also Published As

Publication number Publication date
UA123330C2 (uk) 2021-03-17
RU2771280C2 (ru) 2022-04-29
US20190284177A1 (en) 2019-09-19
CA3030370A1 (en) 2018-01-18
US20200291010A1 (en) 2020-09-17
US10934282B2 (en) 2021-03-02
AU2017294969B2 (en) 2021-03-25
ZA201808436B (en) 2020-05-27
ES2834009T3 (es) 2021-06-16
SA519400868B1 (ar) 2022-06-13
MX383770B (es) 2025-03-14
PL3484880T3 (pl) 2021-04-06
IL264141B (en) 2021-09-30
PT3484880T (pt) 2020-12-07
RU2019103883A (ru) 2020-08-13
NZ749301A (en) 2021-03-26
US10662181B2 (en) 2020-05-26
EP3484880B1 (en) 2020-09-02
JP2019521137A (ja) 2019-07-25
JP7016344B2 (ja) 2022-02-04
IL264141A (en) 2019-02-28
MY196990A (en) 2023-05-17
SG11201811107WA (en) 2019-01-30
CN109476653A (zh) 2019-03-15
WO2018011201A1 (en) 2018-01-18
KR20190026872A (ko) 2019-03-13
CN109476653B (zh) 2022-04-22
RU2019103883A3 (cg-RX-API-DMAC7.html) 2020-09-23
BR112019000486A2 (pt) 2019-04-24
MX2019000361A (es) 2019-05-23
EP3484880A1 (en) 2019-05-22
AU2017294969A1 (en) 2019-01-17
KR102490140B1 (ko) 2023-01-19

Similar Documents

Publication Publication Date Title
SI3743406T1 (sl) Modulatorji TMEM16A
DK3433234T3 (da) Allosteriske modulatorer af nicotinacetylcholinreceptorer
DK3490986T3 (da) Piperidin-cxcr7-receptormodulatorer
SI3507276T1 (sl) Spojine modulatorja toličnih receptorjev
DK3331876T3 (da) Modulators of ror-gamma
IL283967A (en) Modulators of hsd17b13 expression
EP3383386A4 (en) MODULATORS OF CHEMOKIN RECEPTORS
HUE054009T2 (hu) Szubsztituált tetrahidrokinolinon vegyületek ROR gamma modulátorként
DK3300500T3 (da) Triazolagonister af apj-receptoren
EP3442971C0 (en) ESTROGEN RECEPTOR MODULATORS
IL281492A (en) Modulators of pnpla3 expression
LT3322701T (lt) Etinilo dariniai kaip metabotropinių glutamato receptorių moduliatoriai
IL249698A0 (en) Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors
DK3359160T3 (da) Farnesoid x receptor modulatorer
DK3160964T3 (da) Arylreceptormodulatorer og fremgangsmåder til fremstilling og brug af samme
DK3364958T3 (da) Modulatorer af sestrin-gator2-interaktion og anvendelser deraf
DK3157929T3 (da) Pyrazolforbindelser som modulatorer af fshr og anvendelser deraf
IL266505B (en) Heterocyclic modulators of lipid synthesis
HUE048902T2 (hu) Új ROR gamma modulátor vegyületek
IL268731A (en) New uses of anti-sirpg antibodies
DK3685847T5 (da) Modulatorer af komplementaktivitet
DK2964229T3 (da) Benzoimidazol-2-yl-pyrimidinmodulatorer af histamin-h4 receptoren
BR112017026561A2 (pt) moduladores alostéricos positivos do receptor muscarínico m2
DK3104847T3 (da) Hidtil ukendt anvendelse af sigma-1-receptoragonistforbindelser
EP3758494A4 (en) AMIDPRODRUGS OF SMALL MOLECULES NUCLEAR RECEPTOR MODULATORS